ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 21 filings · Latest: Sep 28, 2026
ADARx Pharmaceuticals, Inc.
Adicet Bio, Inc.
BlossomHill Therapeutics, Inc.
Braveheart Bio, Inc.
Electra Therapeutics, Inc.
Enliven Therapeutics, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Scribe Therapeutics, Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PASG | OrbiMed Private Investments VII, LP | — | Jul 15, 2025 | Proposed Sale | $6.79 | 53,293 | $361.9K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 7, 2025 | Proposed Sale | $0.433 | 259,000 | $112.1K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jun 24, 2025 | Proposed Sale | $0.3516 | 1,076,120 | $378.4K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Apr 15, 2025 | Proposed Sale | $0.383 | 787,179 | $301.5K | — | |
CMPX | OrbiMed Genesis Master Fund, L.P. | — | Apr 9, 2025 | Proposed Sale | $1.59 | 3,571,428 | $5.7M | — | |
IRON | OrbiMed Genesis Master Fund, L.P. | — | Mar 10, 2025 | Proposed Sale | $55.67 | 74,800 | $4.2M | — | |
IRON | OrbiMed Private Investments VI, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 193,400 | $10.8M | — | |
IRON | OrbiMed Private Investments VIII, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 299,200 | $16.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jan 6, 2025 | Proposed Sale | $0.829 | 1,140,740 | $945.7K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Dec 4, 2024 | Proposed Sale | $0.89 | 2,985,518 | $2.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Sep 16, 2024 | Proposed Sale | $0.807 | 927,572 | $748.6K | — |
← Previous
Page 3 of 3